As of late 2023, the COVID-19 pandemic continues to evolve with new variants of the SARS-CoV-2 virus emerging. Vaccination campaigns have significantly reduced the number of severe cases and hospitalizations, although breakthrough infections are still being reported. The focus has now shifted towards booster doses and updating vaccines to cover new variants, such as the Omicron sublineages.
